Bu ilacin prospektus bilgilerinden kopi peyst. Annenle ilgili yerleri buyuk harfe cevirdim. Bu ilacin gunde 15 sigaradan fazla icen kadinlara yazilmamasi gerekiyor zaten.
www.mybwmc.orgThe combination of cyproterone and ethinyl estradiol shares many of the risks of oral contraceptive agents. The risk of cardiovascular side effects with oral contraceptives increases in WOMEN WHO SMOKE CIGARETTES, ESPECIALLY THOSE WHO ARE >35 YEARS OF AGE; WOMEN WHO USE COMBINATION estrogen/progestin therapy SHOULD BE STRONGLY ADVISED NOT TO SMOKE. May lead to increased risk of myocardial infarction, use with caution in patients with risk factors for coronary artery disease. May have a dose-related risk of vascular disease, hypertension, and gallbladder disease.
Cardiovascular Considerations
It is important to recognize that estrogen/antiandrogen combinations may induce or worsen hypertension. These problems are less severe with low doses. Furthermore, these agents may precipitate thromboembolic events, PARTICULARLY IN WOMEN WHO SMOKE. It is important that patients on long-term therapy undergo monitoring of blood pressure and avoid cigarette use.
Ozeti su: Annen 35 yasindan buyuk oldugu ve bu ilacla birlikte sigara ictigi icin, damar tikanikligi, kalb krizi, beyin kanamasi, beyin damari tikanikligina bagli felc, yuksek tansiyon, barsaklari besleyen damar tikanikligina bagli barsak gangreni gibi hastaliklar gecirme riski cok artiyor.